BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA initiates coverage on Dr Lal PathLabs with outperform
CLSA has initiated coverage on Dr Lal PathLabs with 'outperform' for target of Rs 1,140/share. It says market share gain for organised players will continue and growth will be led by volumes and will increase with expansion. CLSA expects 19% CAGR growth over FY16-19.